Skip to main content

Table 5 A Comparison of the Diagnostic Performance Between PET/CT-guided Targeted BMB and Iliac Crest Biopsy for the Assessment of Focal Bone marrow disease on PET/CT scan in the 30 patients

From: Is it sufficient to evaluate bone marrow involvement in newly diagnosed lymphomas using 18F-FDG PET/CT and/or routine iliac crest biopsy? A new approach of PET/CT-guided targeted bone marrow biopsy

 

Pathological results

Total

P

+

–

Target bone biopsy(n = 30)

27 (90.0%)

3a (10.0%)

30

< 0.05‡

Routine iliac crest biopsy(n = 30)

5 (16.7%)

25 (83.3%)

30

  1. aNegative results include one Eosinophilic granuloma with fibrosis, one myelodysplastic syndrome (MDS) and one active bone marrow hyperplasia
  2. ‡ Fisher exact test